Related Articles
Psoriasis induced by first‑line pembrolizumab in metastatic non‑small cell lung cancer: A case report
Long‑term survival of a patient with advanced lung cancer treated with targeted therapy and anti‑PD‑1 immunotherapy as multi‑line therapy: A case report
Guillain‑Barre syndrome induced by pembrolizumab and sunitinib: A case report
Anti‑PD‑1 immune checkpoint inhibitor inducing endocrine toxicity in a patient with advanced lung cancer: A case report and literature review
Pseudoprogression presenting as intestinal perforation in non‑small cell lung cancer treated with anti‑PD‑1: A case report